Understanding how hepatitis B virus DNA is controlled in liver cells
Epigenetic Regulation of HBV cccDNA Transcription
This study is looking at how a protein from the hepatitis B virus affects the virus's DNA in liver cells, with the goal of finding new ways to help people with chronic hepatitis B infections get better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10832580 on NIH RePORTER |
What this research studies
This research investigates the mechanisms that regulate the transcription of hepatitis B virus (HBV) DNA in liver cells, focusing on the role of a specific viral protein called HBx. By studying how HBx interacts with host cell factors and influences the structure of HBV DNA, the research aims to uncover new strategies for eliminating or inactivating this viral DNA, which is crucial for curing chronic HBV infections. The researchers have developed specialized cell lines to observe these interactions and the effects of HBx on viral DNA transcription.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with chronic hepatitis B virus infections who are seeking new treatment options.
Not a fit: Patients who do not have hepatitis B virus infections or those who are not chronically infected may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative antiviral treatments that effectively target and eliminate HBV DNA from infected liver cells.
How similar studies have performed: Previous research has shown promising results in understanding viral regulation mechanisms, suggesting that this approach could lead to significant advancements in HBV treatment.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Guo, Haitao — University of Pittsburgh at Pittsburgh
- Study coordinator: Guo, Haitao
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.